TuHURA Biosciences Inc (HURA) — Cash Flow-to-Debt Ratio
TuHURA Biosciences Inc (HURA) has a Cash Flow-to-Debt Ratio of -0.68x as of March 2026, meaning its operating cash flow of $-4.41 Million could theoretically repay -1% of its total liabilities ($6.51 Million) in one year. Explore how efficiently does TuHURA Biosciences Inc generate cash to assess how effectively this company generates cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
TuHURA Biosciences Inc Cash Flow-to-Debt Ratio (2015–2026)
Historical debt coverage capacity for TuHURA Biosciences Inc across 12 annual periods. Also explore how large is TuHURA Biosciences Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for TuHURA Biosciences Inc (2015–2026)
Year-by-year debt coverage analysis for TuHURA Biosciences Inc. For market capitalisation and broader financial context, see TuHURA Biosciences Inc stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | -4.30x | $-27.63 Million | $6.42 Million | ▼ -57.0% |
| 2025 | -2.74x | $-14.73 Million | $5.37 Million | ▼ -126.2% |
| 2024 | -1.21x | $-7.18 Million | $5.92 Million | ▲ +53.3% |
| 2023 | -2.60x | $-7.51 Million | $2.89 Million | ▼ -182.8% |
| 2022 | -0.92x | $-6.56 Million | $7.15 Million | ▲ +85.6% |
| 2021 | -6.37x | $-18.86 Million | $2.96 Million | ▼ -114.8% |
| 2020 | -2.96x | $-7.93 Million | $2.67 Million | ▲ +3.1% |
| 2019 | -3.06x | $-6.33 Million | $2.07 Million | ▲ +49.1% |
| 2018 | -6.01x | $-9.85 Million | $1.64 Million | ▲ +0.2% |
| 2017 | -6.02x | $-8.02 Million | $1.33 Million | ▼ -75.1% |
| 2016 | -3.44x | $-5.15 Million | $1.50 Million | ▼ -203.0% |
| 2015 | -1.13x | $-3.85 Million | $3.40 Million | — |